Barroso-Sousa, R., ZaƱudo, J. G. T., Li, T., Reddy, S. M., Emens, L. A., Kuntz, T. M., Silva, C. A. C., AlDubayan, S. H., Chu, H., Overmoyer, B., Lange, P., DiLullo, M. K., Montesion, M., Kasparian, J., Hughes, M. E., Attaya, V., Basta, A., Lin, N. U., Tayob, N., Jeselsohn, R., Mittendorf, E. A., Tolaney, S. M. (2025). Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS). Nature Communications. https://doi.org/10.1038/s41467-025-59695-1